HCA Healthcare, Inc. (HCA) operating KPIs
HCANYSEServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/301% below fair value
$473.19−4.89 (-1.02%)
Close on Oct 30, 2026Market cap $102.45BP/E 15.7Yield 0.61%
HCA Healthcare outpatient Dialysis & Lab Peers — DaVita Inc. (DVA): Total Revenues ($M)
Quarterly figures from HCA Healthcare's filings and investor materials
Latest, Q2 2026
3,554
Period ended Jun 30, 2026
Change on a year earlier
+5.1%
3,380 in Q2 2025
History
42 quarters
Since Q1 2016
Sources
2
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Outpatient Dialysis & Lab Peers — DaVita Inc. (DVA): Total Revenues ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 3,554 | +5.1% | DaVita Inc. SEC 10-Q (XBRL) ↗ |
| Q1 2026 | Mar 31, 2026 | 3,416 | +6.0% | DaVita Inc. SEC 10-Q (XBRL) ↗ |
| Q4 2025 | Dec 31, 2025 | 3,620 | +9.9% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| Q3 2025 | Sep 30, 2025 | 3,420 | +4.8% | DaVita Inc. SEC 10-Q (XBRL) ↗ |
| Q2 2025 | Jun 30, 2025 | 3,380 | +6.1% | DaVita Inc. SEC 10-Q (XBRL) ↗ |
| Q1 2025 | Mar 31, 2025 | 3,224 | +5.0% | DaVita Inc. SEC 10-Q (XBRL) ↗ |
| Q4 2024 | Dec 31, 2024 | 3,295 | +4.7% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| Q3 2024 | Sep 30, 2024 | 3,264 | +4.6% | DaVita Inc. SEC 10-Q (XBRL) ↗ |
| Q2 2024 | Jun 30, 2024 | 3,187 | +6.2% | DaVita Inc. SEC 10-Q (XBRL) ↗ |
| Q1 2024 | Mar 31, 2024 | 3,071 | +6.9% | DaVita Inc. SEC 10-Q (XBRL) ↗ |
| Q4 2023 | Dec 31, 2023 | 3,146 | +7.9% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| Q3 2023 | Sep 30, 2023 | 3,121 | +5.8% | DaVita Inc. SEC 10-Q (XBRL) ↗ |
| Q2 2023 | Jun 30, 2023 | 3,000 | +2.5% | DaVita Inc. SEC 10-Q (XBRL) ↗ |
| Q1 2023 | Mar 31, 2023 | 2,873 | +2.0% | DaVita Inc. SEC 10-Q (XBRL) ↗ |
| Q4 2022 | Dec 31, 2022 | 2,917 | -0.9% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| Q3 2022 | Sep 30, 2022 | 2,949 | +0.4% | DaVita Inc. SEC 10-Q (XBRL) ↗ |
| Q2 2022 | Jun 30, 2022 | 2,927 | +0.3% | DaVita Inc. SEC 10-Q (XBRL) ↗ |
| Q1 2022 | Mar 31, 2022 | 2,818 | -0.1% | DaVita Inc. SEC 10-Q (XBRL) ↗ |
| Q4 2021 | Dec 31, 2021 | 2,944 | +1.3% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| Q3 2021 | Sep 30, 2021 | 2,938 | +0.5% | DaVita Inc. SEC 10-Q (XBRL) ↗ |
| Q2 2021 | Jun 30, 2021 | 2,917 | +1.3% | DaVita Inc. SEC 10-Q (XBRL) ↗ |
| Q1 2021 | Mar 31, 2021 | 2,820 | -0.7% | DaVita Inc. SEC 10-Q (XBRL) ↗ |
| Q4 2020 | Dec 31, 2020 | 2,905 | +0.2% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| Q3 2020 | Sep 30, 2020 | 2,924 | +0.7% | DaVita Inc. SEC 10-Q (XBRL) ↗ |
| Q2 2020 | Jun 30, 2020 | 2,880 | +1.3% | DaVita Inc. SEC 10-Q (XBRL) ↗ |
| Q1 2020 | Mar 31, 2020 | 2,841 | +3.6% | DaVita Inc. SEC 10-Q (XBRL) ↗ |
| Q4 2019 | Dec 31, 2019 | 2,899 | +2.8% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| Q3 2019 | Sep 30, 2019 | 2,904 | +2.0% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| Q2 2019 | Jun 30, 2019 | 2,843 | -1.5% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| Q1 2019 | Mar 31, 2019 | 2,743 | -3.7% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| Q4 2018 | Dec 31, 2018 | 2,821 | +1.4% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| Q3 2018 | Sep 30, 2018 | 2,847 | +3.0% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| Q2 2018 | Jun 30, 2018 | 2,887 | +7.0% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| Q1 2018 | Mar 31, 2018 | 2,849 | +8.3% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| Q4 2017 | Dec 31, 2017 | 2,781 | +3.0% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| Q3 2017 | Sep 30, 2017 | 2,765 | +1.5% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| Q2 2017 | Jun 30, 2017 | 2,699 | +0.9% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| Q1 2017 | Mar 31, 2017 | 2,631 | +0.9% | DaVita Inc. SEC 10-K (XBRL) ↗ |
| Q4 2016 | Dec 31, 2016 | 2,699 | – | DaVita Inc. SEC 10-K (XBRL) ↗ |
| Q3 2016 | Sep 30, 2016 | 2,725 | – | DaVita Inc. SEC 10-K (XBRL) ↗ |
| Q2 2016 | Jun 30, 2016 | 2,675 | – | DaVita Inc. SEC 10-K (XBRL) ↗ |
| Q1 2016 | Mar 31, 2016 | 2,607 | – | DaVita Inc. SEC 10-K (XBRL) ↗ |
Breakdown
What makes up outpatient dialysis & lab peers — davita inc. (dva): total revenues
Cite this data
StockData. (2026). HCA Healthcare Outpatient Dialysis & Lab Peers — DaVita Inc. (DVA): Total Revenues ($M), quarterly Q1 2016–Q2 2026 [Data set]. Compiled from HCA Healthcare SEC filings and investor materials. https://stockdatahq.com/stocks/hca/kpis/peer_dva_rev
See every metric in the HCA Healthcare KPI table. Data updated Oct 29, 2026.